What is the prevalence of Fibrous Dysplasia?

Fibrous dysplasia is considered a rare bone disorder, with an estimated prevalence ranging from 1 in 15,000 to 1 in 30,000 individuals worldwide. Because many mild cases remain asymptomatic and undiagnosed throughout a person's life, these figures are likely underestimates of the true clinical prevalence.

Is fibrous dysplasia considered a rare disease?

Yes, fibrous dysplasia is classified as a rare disease. It is a non-hereditary skeletal disorder where normal bone and marrow are replaced by fibrous tissue, leading to weakened bone structure, deformities, and potential fractures. While the condition is rare, it is one of the most common benign fibro-osseous lesions of the bone. Accurate global prevalence data for fibrous dysplasia is difficult to capture because the disease spectrum is broad; some individuals may have a single lesion (monostotic) that never causes symptoms, while others have widespread involvement (polyostotic) that requires significant medical intervention.

How does the prevalence of fibrous dysplasia vary by demographics?

Epidemiological data regarding fibrous dysplasia indicates several key demographic trends:

• Gender Distribution: Most clinical literature suggests that fibrous dysplasia affects males and females with roughly equal frequency.


• Age of Onset: The condition typically presents during childhood or adolescence, often becoming clinically apparent in the first or second decade of life. While it is predominantly a pediatric diagnosis, it persists into adulthood.


• Geographic and Ethnic Variation: There is currently no robust evidence to suggest that fibrous dysplasia is more prevalent in any specific geographic region or ethnic group.

Why is it difficult to determine the exact number of cases?

The primary challenge in establishing exact prevalence statistics for fibrous dysplasia is underdiagnosis. Many individuals with the monostotic form of the disease may never experience pain or fracture, meaning they never seek medical attention and are never entered into clinical registries. Furthermore, in the DiseaseMaps.org community, 280 people with fibrous dysplasia have shared their experiences, providing a crucial real-world perspective that complements formal clinical data. These community registries help researchers understand the "hidden" burden of the disease that is often missed in traditional hospital-based prevalence studies.

What is the difference between monostotic and polyostotic prevalence?

Clinicians distinguish between two main forms, which significantly impacts how the disease is categorized in statistics:

1. Monostotic Fibrous Dysplasia: This involves only one bone and accounts for approximately 70% to 80% of all cases. It is the most frequently encountered form.


2. Polyostotic Fibrous Dysplasia: This involves multiple bones and is significantly rarer. It may be associated with McCune-Albright syndrome, a condition involving endocrine abnormalities and skin pigmentation.

Next steps

• Consult an orthopedic oncologist or an endocrinologist specializing in metabolic bone diseases if you suspect symptoms of fibrous dysplasia.


• Request a referral to a center of excellence that specializes in skeletal dysplasias for accurate imaging and diagnostic workup.


• Connect with the 280-member community at DiseaseMaps.org to share experiences and learn from others living with the condition.


• Maintain regular monitoring with X-rays or bone scans as recommended by your physician to track lesion stability.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Orphanet: Fibrous dysplasia of bone (ORPHA:333)


• NIH Genetic and Rare Diseases Information Center (GARD): Fibrous Dysplasia


• OMIM (Online Mendelian Inheritance in Man): Fibrous Dysplasia of Bone (Entry #174800)


• Fibrous Dysplasia Foundation: Clinical information and patient resources